Relationship between cell cycle and cancer development: Therapeutical approaches.

被引:3
作者
PeraltaZaragoza, O [1 ]
BahenaRoman, M [1 ]
DiazBenitez, CE [1 ]
MadridMarina, V [1 ]
机构
[1] INST NACL SALUD PUBL, CTR INVEST ENFERMEDADES INFECCIOSAS, AREA VIROL MOL, CUERNAVACA 62508, MORELOS, MEXICO
来源
SALUD PUBLICA DE MEXICO | 1997年 / 39卷 / 05期
关键词
cell cycle; gene expression regulation; antineoplastic agents; combined; Mexico;
D O I
10.1590/S0036-36341997000500008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Several genetic alterations occur during the transformation process from normal to tumor cells, that involve the loss of fidelity of processes as replication, reparation, and segregation of the genomic material. Although normal cells have defense mechanisms against cancer progression, in tumor cells different escape pathways are activated leading to tumor progression. Recent advances have permitted cancer research to focus on the identification of some of its etiological factors. The knowledge of cell cycle reveals a precise mechanism achieved by the coordinated interactions and functions of cyclin-dependent kinases, control checkpoint, and repair pathways. Furthermore, it has been demonstrated that this cordinated function can be abrogated by specific genetic changes. These findings suggest that the molecular mechanisms responsible for cellular transformation may help to identify potential targets to improve cancer therapies.
引用
收藏
页码:451 / 462
页数:12
相关论文
共 79 条
  • [1] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [2] INCREASED SPINDLE RESISTANCE TO ANTIMICROTUBULE AGENTS IN CELLS PRONE TO CHROMOSOMAL NONDISJUNCTION
    AVIVI, L
    DOTAN, A
    RAVIA, Y
    AMIEL, A
    SHACHAM, H
    NEUMANN, Y
    [J]. HUMAN GENETICS, 1989, 83 (02) : 165 - 170
  • [3] BARRERARODRIGUEZ R, 1995, SALUD PUBLICA MEXICO, V37, P344
  • [4] CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1
  • [5] TELOMERASE ACTIVITY IN HUMAN OVARIAN-CARCINOMA
    COUNTER, CM
    HIRTE, HW
    BACCHETTI, S
    HARLEY, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 2900 - 2904
  • [6] THE TUMOR-SUPPRESSOR P53
    DONEHOWER, LA
    BRADLEY, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1155 (02) : 181 - 205
  • [7] P53-DEPENDENT INHIBITION OF CYCLIN-DEPENDENT KINASE-ACTIVITIES IN HUMAN FIBROBLASTS DURING RADIATION-INDUCED G1 ARREST
    DULIC, V
    KAUFMANN, WK
    WILSON, SJ
    TLSTY, TD
    LEES, E
    HARPER, JW
    ELLEDGE, SJ
    REED, SI
    [J]. CELL, 1994, 76 (06) : 1013 - 1023
  • [8] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [9] MUTATION OF FISSION YEAST-CELL CYCLE CONTROL GENES ABOLISHES DEPENDENCE OF MITOSIS ON DNA-REPLICATION
    ENOCH, T
    NURSE, P
    [J]. CELL, 1990, 60 (04) : 665 - 673
  • [10] ANALYSIS OF PURINE METABOLIC ENZYMES IN HUMAN CD4 LEU-8- AND CD4 LEU-8+ LYMPHOCYTE SUBPOPULATIONS
    FERNANDEZMEJIA, C
    POLMAR, SH
    PERALTZARAGOZA, O
    MADRIDMARINA, V
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1993, 25 (02): : 213 - 218